CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Monday reported a loss of $110 million in its third quarter.

The Carlsbad, California-based company said it had a loss of 66 cents per share. Losses, adjusted for stock option expense, were 40 cents per share.

The drug discovery and development company posted revenue of $243 million in the period, topping Street forecasts. Eight analysts surveyed by Zacks expected $178.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS